NVCR : NovoCure Limited stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2022-01-14 |
|---|---|---|---|---|
| 2022 | $86.73 | $69.85 | $116.8 | 25.48% |
| 2023 | $192.75 | $126.81 | $256.83 | 178.87% |
| 2024 | $292.61 | $266.96 | $305.35 | 323.34% |
| 2025 | $310.12 | $306.31 | $314.72 | 348.66% |
| 2026 | $315.72 | $314.98 | $319.52 | 356.77% |
| 2027 | $320.17 | $320.06 | $320.25 | 363.21% |
| 2028 | $319.81 | $319.29 | $320.2 | 362.68% |
| 2029 | $317.19 | $311.27 | $319.17 | 358.9% |
| 2030 | $250.0 | $191.81 | $306.25 | 261.68% |
| 2031 | $171.94 | $163.02 | $185.76 | 148.76% |
| 2032 | $161.61 | $161.61 | $161.61 | 133.82% |
The 2 Wall Street analysts offering NovoCure Limited stock forecast in the last 6 months have average price target of
$190.0 with a high forecast of $200.0 and a low forecast of $180.0.
The average NovoCure Limited stock forecast represents a 174.88%
increase from the last price of $69.120002746582.
From AI system, total return is 3138.37% from 3070 forecasts.
For NovoCure Limited stock forecast for 2022, 11 predictions are offered for each month of 2022 with average NovoCure Limited stock
forecast of $86.73, a high forecast of $116.8, and a low forecast of $69.85.
The average NovoCure Limited stock forecast 2022 represents a 25.48%
increase from the last price of $69.120002746582.
For NovoCure Limited stock forecast for 2023, 12 predictions are offered for each month of 2023 with average NovoCure Limited stock
forecast of $192.75, a high forecast of $256.83, and a low forecast of $126.81.
The average NovoCure Limited stock forecast 2023 represents a 178.87%
increase from the last price of $69.120002746582.
For NovoCure Limited stock forecast for 2025, 12 predictions are offered for each month of 2025 with average NovoCure Limited stock
forecast of $310.12, a high forecast of $314.72, and a low forecast of $306.31.
The average NovoCure Limited stock forecast 2025 represents a 348.66%
increase from the last price of $69.120002746582.
For NovoCure Limited stock forecast for 2027 (5 year), 12 predictions are offered for each month of 2027 with average NovoCure Limited stock
forecast of $320.17, a high forecast of $320.25, and a low forecast of $320.06.
The average NovoCure Limited stock forecast 2027 represents a 363.21%
increase from the last price of $69.120002746582.
For NovoCure Limited stock forecast for 2030, 12 predictions are offered for each month of 2030 with average NovoCure Limited stock
forecast of $250.0, a high forecast of $306.25, and a low forecast of $191.81.
The average NovoCure Limited stock forecast 2030 represents a 261.68%
increase from the last price of $69.120002746582.
For NovoCure Limited stock forecast for 2032 (10 year), 1 predictions are offered for each month of 2032 with average NovoCure Limited stock
forecast of $161.61, a high forecast of $161.61, and a low forecast of $161.61.
The average NovoCure Limited stock forecast 2032 represents a 133.82%
increase from the last price of $69.120002746582.
Please, see more forecasts below.
NVCR : NovoCure Limited stock forecast by Wall Street Analysts
The average NovoCure Limited stock forecast from last 6 month is $190.0, and this show a -14.41% decrease in average from the prior price target of the each prediction. Also, this average forecast of $190.0 represents a -0.37% decrease from the past average forecast of $190.71, 6 months ago from 7 wall street analysts.
NovoCure Limited stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2022-01-18 | $68.55 | -0.83% |
| 2022-01-19 | $66.90 | -2.41% |
| 2022-01-20 | $67.08 | 0.28% |
| 2022-01-21 | $68.14 | 1.58% |
| 2022-01-24 | $69.81 | 2.44% |
NVCR : Long term NovoCure Limited stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2022 Feb. is $69.85 , for 2023 Jan. is $126.81 , for 2026 Jan. is $314.98 , for 2027 Jan. is $320.11 , for 2031 Jan. is $185.76 , and for 2032 Jan. is $161.61.
NVCR : NovoCure Limited stock forecast for 2022
| Date | Price Target | Change |
|---|---|---|
| 2022 Feb. | $69.85 | 1.06% |
| 2022 Mar. | $71.16 | 1.87% |
| 2022 Apr. | $73.09 | 2.72% |
| 2022 May. | $75.79 | 3.69% |
| 2022 Jun. | $78.91 | 4.12% |
| 2022 Jul. | $82.70 | 4.81% |
| 2022 Aug. | $86.90 | 5.08% |
| 2022 Sep. | $92.37 | 6.29% |
| 2022 Oct. | $99.03 | 7.22% |
| 2022 Nov. | $107.46 | 8.50% |
| 2022 Dec. | $116.80 | 8.70% |
NVCR : NovoCure Limited stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Jan. | $126.81 | 8.57% |
| 2023 Feb. | $138.29 | 9.05% |
| 2023 Mar. | $149.71 | 8.26% |
| 2023 Apr. | $161.53 | 7.90% |
| 2023 May. | $174.05 | 7.75% |
| 2023 Jun. | $186.81 | 7.33% |
| 2023 Jul. | $199.90 | 7.01% |
| 2023 Aug. | $212.80 | 6.45% |
| 2023 Sep. | $224.59 | 5.54% |
| 2023 Oct. | $235.52 | 4.86% |
| 2023 Nov. | $246.17 | 4.52% |
| 2023 Dec. | $256.83 | 4.33% |
NVCR : NovoCure Limited stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $266.96 | 3.95% |
| 2024 Feb. | $275.65 | 3.25% |
| 2024 Mar. | $282.50 | 2.49% |
| 2024 Apr. | $287.80 | 1.87% |
| 2024 May. | $291.91 | 1.43% |
| 2024 Jun. | $295.11 | 1.09% |
| 2024 Jul. | $297.70 | 0.88% |
| 2024 Aug. | $299.74 | 0.68% |
| 2024 Sep. | $301.44 | 0.57% |
| 2024 Oct. | $302.93 | 0.50% |
| 2024 Nov. | $304.22 | 0.43% |
| 2024 Dec. | $305.35 | 0.37% |
NVCR : NovoCure Limited stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $306.31 | 0.31% |
| 2025 Feb. | $307.13 | 0.27% |
| 2025 Mar. | $307.82 | 0.22% |
| 2025 Apr. | $308.40 | 0.19% |
| 2025 May. | $308.88 | 0.16% |
| 2025 Jun. | $309.30 | 0.14% |
| 2025 Jul. | $309.71 | 0.13% |
| 2025 Aug. | $310.25 | 0.18% |
| 2025 Sep. | $311.37 | 0.36% |
| 2025 Oct. | $313.30 | 0.62% |
| 2025 Nov. | $314.22 | 0.30% |
| 2025 Dec. | $314.72 | 0.16% |
NVCR : NovoCure Limited stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $314.98 | 0.08% |
| 2026 Feb. | $315.11 | 0.04% |
| 2026 Mar. | $315.18 | 0.02% |
| 2026 Apr. | $315.21 | 0.01% |
| 2026 May. | $315.22 | 0.00% |
| 2026 Jun. | $315.22 | -0.00% |
| 2026 Jul. | $315.21 | -0.00% |
| 2026 Aug. | $315.21 | -0.00% |
| 2026 Sep. | $315.21 | 0.00% |
| 2026 Oct. | $315.39 | 0.06% |
| 2026 Nov. | $317.12 | 0.55% |
| 2026 Dec. | $319.52 | 0.76% |
NVCR : NovoCure Limited stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $320.11 | 0.18% |
| 2027 Feb. | $320.18 | 0.02% |
| 2027 Mar. | $320.14 | -0.01% |
| 2027 Apr. | $320.06 | -0.02% |
| 2027 May. | $320.09 | 0.01% |
| 2027 Jun. | $320.14 | 0.02% |
| 2027 Jul. | $320.19 | 0.01% |
| 2027 Aug. | $320.22 | 0.01% |
| 2027 Sep. | $320.24 | 0.01% |
| 2027 Oct. | $320.25 | 0.00% |
| 2027 Nov. | $320.24 | -0.00% |
| 2027 Dec. | $320.23 | -0.01% |
NVCR : NovoCure Limited stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $320.20 | -0.01% |
| 2028 Feb. | $320.16 | -0.01% |
| 2028 Mar. | $320.11 | -0.02% |
| 2028 Apr. | $320.04 | -0.02% |
| 2028 May. | $319.97 | -0.02% |
| 2028 Jun. | $319.89 | -0.03% |
| 2028 Jul. | $319.80 | -0.03% |
| 2028 Aug. | $319.71 | -0.03% |
| 2028 Sep. | $319.61 | -0.03% |
| 2028 Oct. | $319.51 | -0.03% |
| 2028 Nov. | $319.40 | -0.03% |
| 2028 Dec. | $319.29 | -0.04% |
NVCR : NovoCure Limited stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $319.17 | -0.04% |
| 2029 Feb. | $319.04 | -0.04% |
| 2029 Mar. | $318.89 | -0.05% |
| 2029 Apr. | $318.71 | -0.06% |
| 2029 May. | $318.49 | -0.07% |
| 2029 Jun. | $318.22 | -0.09% |
| 2029 Jul. | $317.87 | -0.11% |
| 2029 Aug. | $317.42 | -0.14% |
| 2029 Sep. | $316.83 | -0.18% |
| 2029 Oct. | $315.94 | -0.28% |
| 2029 Nov. | $314.46 | -0.47% |
| 2029 Dec. | $311.27 | -1.01% |
NVCR : NovoCure Limited stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $306.25 | -1.62% |
| 2030 Feb. | $299.18 | -2.31% |
| 2030 Mar. | $290.53 | -2.89% |
| 2030 Apr. | $280.93 | -3.30% |
| 2030 May. | $270.59 | -3.68% |
| 2030 Jun. | $259.49 | -4.10% |
| 2030 Jul. | $247.17 | -4.75% |
| 2030 Aug. | $232.49 | -5.94% |
| 2030 Sep. | $217.11 | -6.61% |
| 2030 Oct. | $205.96 | -5.14% |
| 2030 Nov. | $198.44 | -3.65% |
| 2030 Dec. | $191.81 | -3.34% |
NVCR : NovoCure Limited stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $185.76 | -3.16% |
| 2031 Feb. | $183.22 | -1.36% |
| 2031 Mar. | $181.72 | -0.82% |
| 2031 Apr. | $176.78 | -2.72% |
| 2031 May. | $171.93 | -2.75% |
| 2031 Jun. | $169.09 | -1.65% |
| 2031 Jul. | $167.82 | -0.75% |
| 2031 Aug. | $167.20 | -0.37% |
| 2031 Sep. | $166.58 | -0.37% |
| 2031 Oct. | $165.72 | -0.52% |
| 2031 Nov. | $164.46 | -0.76% |
| 2031 Dec. | $163.02 | -0.88% |
NVCR : NovoCure Limited stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $161.61 | -0.86% |
Financial Data for NovoCure Limited stock
Frequently Asked Questions about NovoCure Limited stock forecast
Is NovoCure Limited a good long term stock?
From NovoCure Limited stock forecast , NovoCure Limited (NVCR) stock can be a good investment choice. According to AI Pickup, the NovoCure Limited stock price forecast for 2022 Feb. is $69.8531102279603 From NovoCure Limited stock forecast , NovoCure Limited (NVCR) stock can be a good investment choice. According to AI Pickup, the NovoCure Limited stock price forecast for 2023 Jan. is $126.813559327008 From NovoCure Limited stock forecast , NovoCure Limited (NVCR) stock can be a good investment choice. According to AI Pickup, the NovoCure Limited stock price forecast for 2026 Jan. is $314.977427238966 From NovoCure Limited stock forecast , NovoCure Limited (NVCR) stock can be a good investment choice. According to AI Pickup, the NovoCure Limited stock price forecast for 2027 Jan. is $320.109895456214 From NovoCure Limited stock forecast , NovoCure Limited (NVCR) stock can be a good investment choice. According to AI Pickup, the NovoCure Limited stock price forecast for 2031 Jan. is $185.756392893366 From NovoCure Limited stock forecast , NovoCure Limited (NVCR) stock can be a good investment choice. According to AI Pickup, the NovoCure Limited stock price forecast for 2032 Jan. is $161.61371672404
Is NovoCure Limited stock overvalued?
NovoCure Limited (NVCR) stock is expected to go UP . Therefore, AI Pickup would say that NovoCure Limited (NVCR) stock is NOT overvalued.
Will NovoCure Limited stock price go up?
Yes. The NovoCure Limited stock price forecast for 2023 Jan. is $126.813559327008
Is NovoCure Limited stock a good buy now?
Since closing price on 2022-01-14 is $69.120002746582 and forecast for 2023 Jan. is $126.81, NovoCure Limited stock is a good 1 year investment.